Premium
Rituximab in a risk‐adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte‐predominant Hodgkin lymphoma
Author(s) -
Della Pepa Roberta,
Picardi Marco,
Giordano Claudia,
Zacheo Irene,
Pugliese Novella,
Cerchione Claudio,
Raimondo Marta,
Di Perna Maria,
Troncone Giancarlo,
Ciancia Giuseppe,
Intrieri Mariano,
Pane Fabrizio
Publication year - 2018
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.14856
Subject(s) - rituximab , medicine , lymphoma , immunology , lymphocyte , hodgkin lymphoma , oncology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom